Natriuretic peptides BNP and NT-proBNP serve dual roles in diabetes care — as biomarkers for heart failure risk stratification and as potential guides for targeted cardiovascular therapy.
BNP/NT-proBNPdual-role peptide biomarkers for heart failure risk and treatment guidance in diabetes
What the researchers found
Elevated BNP and NT-proBNP levels in diabetes patients correlate with cardiac abnormalities and can be used for heart failure risk stratification and potentially for guiding treatment strategies.
Why it matters
Heart failure is one of the most serious and common complications of diabetes. Natriuretic peptide testing offers a relatively simple blood test that can help identify at-risk patients early and guide treatment intensity.
The numbers in context
Altered SP levels detected in brain, spinal cord, and cerebrospinal fluid of ALS patients and preclinical models.
How the study worked
Narrative review synthesizing evidence on natriuretic peptide biology, diagnostic utility, and therapeutic guidance potential in the context of diabetes and heart failure.
Who was studied
ALS patients and preclinical models
What this study cannot tell us
Review article without new primary data; NP-guided therapy evidence is still evolving; NP levels can be influenced by factors beyond cardiac function (obesity, kidney disease); lacks specific treatment algorithms; focused primarily on type 2 diabetes.
How to read the evidence
Strong evidence for NP as diagnostic/prognostic biomarkers; moderate and evolving evidence for NP-guided therapy in diabetes populations specifically.
When this study was published
Published in 2024, reflecting current evidence and emerging perspectives on NP-guided care in diabetes.
The bigger picture
As the diabetes epidemic continues to grow globally, so does the burden of diabetes-related heart failure. Using natriuretic peptides as both diagnostic and therapeutic guides could help clinicians catch heart problems earlier and treat them more effectively in this high-risk population.
Questions still open
- Should all diabetes patients undergo routine natriuretic peptide screening?
- Can NP-guided therapy reduce heart failure hospitalizations in diabetes patients?
- How do newer diabetes drugs like SGLT2 inhibitors and GLP-1 agonists affect natriuretic peptide levels?
Common questions
What are natriuretic peptides and why do they matter for diabetes?
Should people with diabetes get natriuretic peptide testing?
Read the original research
Perspective role of Substance P in Amyotrophic Lateral Sclerosis: From neuronal vulnerability to neuroprotection.
Neuroscience and biobehavioral reviews, 167, 105914
Citation
Tirassa, Paola; Rosso, Pamela; Fico, Elena; Marenco, Marco; Mallone, Fabiana; Gharbiya, Magda; Lambiase, Alessandro; Severini, Cinzia. (2024). Perspective role of Substance P in Amyotrophic Lateral Sclerosis: From neuronal vulnerability to neuroprotection.. Neuroscience and biobehavioral reviews, 167, 105914. https://doi.org/10.1016/j.neubiorev.2024.105914